No takes yet. Share an insight, caveat, or question.
Comprehensive review highlights long ncRNAs' role in OSCC treatment and drug resistance mechanisms.
Sadeghzade et al. (2025) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: